S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2014 RESULTS; PROVIDES 2015 FINANCIAL GUIDANCE (2015/1/27)|
|Pfizer Marks World Cancer Day with Grant to Union for International Cancer Control to Address the Needs of Metastatic Breast Cancer Patients (2015/2/4)|
|Pfizer Announces FDA Acceptance For Review Of Supplemental New Drug Application For Oral XELJANZ® (tofacitinib citrate) For Adult Patients With Moderate To Severe Chronic Plaque Psoriasis (2015/2/4)|
|Pfizer Announces Positive Top-line Results Of A Phase 2 Study Of TRUMENBA® (Meningococcal Group B Vaccine) Co-Administered With Routine Meningococcal (A, C, Y, and W) And Tetanus, Diptheria And Pertussis (Tdap) Vaccines In Adolescents (2015/2/24)|
|Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) (2015/2/13)|
|Pfizer Invites Public to View and Listen to Webcast of January 27 Conference Call with Analysts (2014/12/16)|
|Pfizer Hit by Stronger Dollar, Patent Losses, Lawsuit Settlement -- 3rd Update (2015/1/27)|
|Pfizer Expands Rare Disease Research with Establishment of Gene Therapy Platform (2014/12/8)|
|Newly Approved Ibrance® (Palbociclib) from Pfizer Available Through Onco360 (2015/2/9)|
|Pfizer Initiates Phase 2 Study of PF-06252616 in Duchenne Muscular Dystrophy (2014/12/17)|
Click above to view more mutual fund data and stats for pfizer - Pfizer Ltd.